A detailed history of F&V Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, F&V Capital Management, LLC holds 167,488 shares of BMY stock, worth $8.23 Million. This represents 2.03% of its overall portfolio holdings.

Number of Shares
167,488
Previous 158,308 5.8%
Holding current value
$8.23 Million
Previous $8.59 Million 18.97%
% of portfolio
2.03%
Previous 2.53%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$40.25 - $52.99 $369,495 - $486,448
9,180 Added 5.8%
167,488 $6.96 Million
Q1 2024

Apr 15, 2024

BUY
$47.98 - $54.4 $215,190 - $243,984
4,485 Added 2.92%
158,308 $8.59 Million
Q4 2023

Jan 17, 2024

BUY
$48.48 - $57.85 $10,665 - $12,727
220 Added 0.14%
153,823 $7.89 Million
Q3 2023

Oct 24, 2023

SELL
$57.89 - $64.73 $107,964 - $120,721
-1,865 Reduced 1.2%
153,603 $8.92 Million
Q2 2023

Jul 20, 2023

SELL
$63.71 - $70.74 $103,847 - $115,306
-1,630 Reduced 1.04%
155,468 $9.94 Million
Q1 2023

Apr 17, 2023

BUY
$65.71 - $74.53 $443,871 - $503,450
6,755 Added 4.49%
157,098 $10.9 Million
Q4 2022

Jan 17, 2023

BUY
$68.48 - $81.09 $17,120 - $20,272
250 Added 0.17%
150,343 $10.8 Million
Q3 2022

Oct 21, 2022

BUY
$0.13 - $76.84 $351 - $207,468
2,700 Added 1.83%
150,093 $10.7 Million
Q2 2022

Jul 25, 2022

BUY
$72.62 - $79.98 $383,796 - $422,694
5,285 Added 3.72%
147,393 $11.3 Million
Q1 2022

Apr 08, 2022

BUY
$61.48 - $73.72 $9,222 - $11,058
150 Added 0.11%
142,108 $10.4 Million
Q4 2021

Jan 20, 2022

BUY
$53.63 - $62.52 $665,280 - $775,560
12,405 Added 9.58%
141,958 $8.85 Million
Q3 2021

Oct 12, 2021

BUY
$59.17 - $69.31 $115,677 - $135,501
1,955 Added 1.53%
129,553 $7.67 Million
Q2 2021

Jul 09, 2021

BUY
$61.91 - $67.42 $2.92 Million - $3.18 Million
47,173 Added 58.65%
127,598 $8.53 Million
Q1 2021

Apr 08, 2021

BUY
$59.34 - $66.74 $4.34 Million - $4.88 Million
73,121 Added 1001.11%
80,425 $5.08 Million
Q4 2020

Jan 11, 2021

BUY
$57.74 - $65.43 $229,516 - $260,084
3,975 Added 119.41%
7,304 $453,000
Q3 2020

Oct 09, 2020

BUY
$57.43 - $63.64 $191,184 - $211,857
3,329 New
3,329 $201,000
Q1 2020

Apr 07, 2020

SELL
$46.4 - $67.43 $159,105 - $231,217
-3,429 Closed
0 $0
Q4 2019

Jan 15, 2020

BUY
$49.21 - $64.19 $168,741 - $220,107
3,429 New
3,429 $220,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $104B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track F&V Capital Management, LLC Portfolio

Follow F&V Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of F&V Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on F&V Capital Management, LLC with notifications on news.